Evolva teams up with FCI to expand nootkatone and valencene sales & marketing in Europe

16 March 2017 – Evolva announces that it is teaming up with Paris-based FCI to expand the European sales, marketing and distribution of its high-purity, sustainably sourced citrus ingredients, nootkatone and valencene.

Nootkatone is a molecule that gives grapefruit its distinct aromatic scent. It is extracted in minute quantities from the skin of grapefruit and the bark of the Nootka cypress tree for a variety of artisanal products. Given its minute presence in the tree bark and grapefruit skin, this supply route results in prohibitively high costs. Evolva’s nootkatone is a high-purity ingredient, free of environmental contaminants and with a traceable and reliable supply chain based on fermentation — the same natural process used to make wine, beer, bread and many other products.

With its trademark aromatic scent of orange peel, Evolva’s valencene is produced from the same fermentation process. Like nootkatone, Evolva’s valencene is giving the flavour and fragrance (F&F) industry an alternative, fully traceable and reliable supply chain for this popular citrus ingredient.

Philippe Faucher Managing Director of FCI said: “The European market for F&F ingredients is well known for its high standards, particularly for use in personal care, food, and beverage products. We see growing demand for ingredients like Evolva’s nootkatone and valencene, and are confident that they will fit well into our portfolio of high-impact chemicals and high added-value molecules.”

Evolva Head of Sales & Marketing Luc Gruner said, “Teaming up with FCI in Europe represents the next phase in the commercial expansion strategy for our nootkatone and valencene. FCI not only recognises, their distinct value proposition, but perhaps more importantly, has the commercial expertise and distribution network that we need now to start ramping up the sales of these high-purity, sustainably sourced citrus ingredients.”

For further information please contact:

Evolva
Luc Gruner
lucg@evolva.com
+ 41 61 485 2152

Michael Malone
michaelma@evolva.com
+ 41 61 485 21 56

FCI
Philippe Faucher, Managing Director
info@fcifr.com
+ 33 1 34 25 58 10

About Evolva

Evolva solves the supply chain issues of nature through a 21st century mix of biotechnology and brewing. We develop, make and sell natural ingredients that provide significant benefits to people in daily life, but whose supply chain issues have limited their use until now. Our flagship ingredients are stevia, nootkatone and resveratrol, but we work on many more, both on our own behalf and with others. To make our world sustainable requires nature and technology to work together as one, and our aim is to play a (small) part in achieving this transformation. We operate internationally. For more information see www.evolva.com. Questions about our approach? Have a look at our video.

About FCI

The FCI team of seasoned professionals has served our worldwide flavor, fragrance and pharmaceutical clients for more than 30 years and is well equipped to handle your fine ingredients needs. FCI provides sales, customer service, quality control, regulatory, warehouse and distribution services along with a substantial inventory of products. FCI is the French subsidiary of Apiscent labs, formely Fontarôme Chemical Inc.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments

Click here to read the press release.